Granite Point Capital Management, L.P. Global Blood Therapeutics, Inc. Call Options Transaction History

Granite Point Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 11, 2022	SELL	$24.9 - $40.26 $2.79 Million - $4.51 Million	-112,100 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$32.46 - $43.42 $1.23 Million - $1.65 Million	-37,900 Reduced 25.27%	112,100 $3.93 Million
Q1 2021 May 12, 2021	BUY	$38.94 - $50.85 $1.78 Million - $2.32 Million	45,700 Added 43.82%	150,000 $6.11 Million
Q4 2020 Feb 05, 2021	BUY	$37.65 - $63.77 $3.93 Million - $6.65 Million	104,300 New	104,300 $4.52 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Granite Point Capital Management, L.P. with notifications on news.